11/13/24 17:35 | 11/11/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S | -1,669 | 55.62 | 0 | -30 | -10 | 282 | D | | | | | | | | | | | | | | |
10/15/24 18:00 | 10/13/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 8 | 3 | 312 | D | | | | | | | | | | | | | | |
10/15/24 18:00 | 10/14/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -199 | 46.28 | 0 | -4 | -1 | 312 | D | | | | | | | | | | | | | | |
4/17/24 17:45 | 4/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 374 | 19.12 | 0 | 20 | 5 | 408 | D | | | | | | | | | | | | | | |
4/17/24 17:45 | 4/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,173 | 59.91 | 0 | -20 | -5 | 408 | D | | | | | | | | | | | | | | |
3/18/24 17:45 | 3/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 382 | 19.12 | 0 | 20 | 5 | 408 | D | | | | | | | | | | | | | | |
3/18/24 17:45 | 3/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,450 | 72.48 | 0 | -20 | -5 | 408 | D | | | | | | | | | | | | | | |
3/12/24 17:45 | 3/10/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 0 | 0.00 | 0 | 28 | 7 | 408 | D | | | | | | | | | | | | | | |
3/12/24 17:45 | 3/11/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.dm | -1,108 | 77.04 | 0 | -14 | -3 | 408 | D | | | | | | | | | | | | | | |
2/21/24 17:45 | 2/18/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 13 | 3 | 394 | D | | | | | | | | | | | | | | |
2/21/24 17:45 | 2/20/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -507 | 79.67 | 0 | -6 | -2 | 394 | D | | | | | | | | | | | | | | |
2/16/24 17:45 | 2/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 382 | 19.12 | 0 | 20 | 5 | 387 | D | | | | | | | | | | | | | | |
2/16/24 17:45 | 2/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,607 | 80.36 | 0 | -20 | -5 | 387 | D | | | | | | | | | | | | | | |
1/31/24 17:45 | 1/29/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 956 | 19.12 | 0 | 50 | 15 | 387 | D | | | | | | | | | | | | | | |
1/31/24 17:45 | 1/29/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -3,026 | 60.51 | 0 | -50 | -11 | 387 | D | | | | | | | | | | | | | | |
1/18/24 17:45 | 1/16/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 382 | 19.12 | 0 | 20 | 5 | 387 | D | | | | | | | | | | | | | | |
1/18/24 17:45 | 1/16/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,250 | 62.50 | 0 | -20 | -5 | 387 | D | | | | | | | | | | | | | | |
6/1/23 17:44 | 5/30/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 387 | D | | | | | | | | | | | | | | |
6/1/23 17:44 | 5/30/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,622 | 64.88 | 0 | -25 | -6 | 387 | D | | | | | | | | | | | | | | |
4/27/23 17:37 | 4/25/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 387 | D | | | | | | | | | | | | | | |
4/27/23 17:37 | 4/25/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,267 | 50.67 | 0 | -25 | -6 | 387 | D | | | | | | | | | | | | | | |
3/31/23 17:49 | 3/29/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 387 | D | | | | | | | | | | | | | | |
3/31/23 17:49 | 3/29/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,112 | 44.46 | 0 | -25 | -6 | 387 | D | | | | | | | | | | | | | | |
3/14/23 17:47 | 3/10/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 0 | 0.00 | 0 | 21 | 6 | 387 | D | | | | | | | | | | | | | | |
3/1/23 18:11 | 2/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 376 | D | | | | | | | | | | | | | | |
3/1/23 18:11 | 2/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,206 | 48.25 | 0 | -25 | -6 | 376 | D | | | | | | | | | | | | | | |
2/22/23 17:38 | 2/18/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 13 | 4 | 376 | D | | | | | | | | | | | | | | |
1/31/23 17:34 | 1/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 369 | D | | | | | | | | | | | | | | |
1/31/23 17:34 | 1/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,287 | 51.47 | 0 | -25 | -6 | 369 | D | | | | | | | | | | | | | | |
12/30/22 17:33 | 12/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 369 | D | | | | | | | | | | | | | | |
12/30/22 17:33 | 12/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,023 | 40.93 | 0 | -25 | -6 | 369 | D | | | | | | | | | | | | | | |
12/8/22 17:35 | 12/6/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 105 | 1.81 | 0 | 58 | 19 | 369 | D | | | | | | | | | | | | | | |
12/6/22 17:49 | 12/3/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 40 | 15 | 311 | D | | | | | | | | | | | | | | |
11/30/22 17:36 | 11/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
11/30/22 17:36 | 11/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,351 | 54.03 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
10/28/22 17:43 | 10/26/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 421 | 16.84 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
10/28/22 17:43 | 10/26/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,370 | 54.81 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
9/30/22 17:42 | 9/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 405 | 16.21 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
9/30/22 17:42 | 9/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,615 | 64.61 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
8/31/22 17:45 | 8/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 405 | 16.21 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
8/31/22 17:45 | 8/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,671 | 66.84 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
7/29/22 17:38 | 7/27/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 375 | 15.00 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
7/29/22 17:38 | 7/27/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,898 | 75.91 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
7/1/22 18:00 | 6/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 314 | 12.57 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
7/1/22 18:00 | 6/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,540 | 61.59 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
3/14/22 18:12 | 3/10/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 0 | 0.00 | 0 | 21 | 8 | 290 | D | | | | | | | | | | | | | | |